TLR2 signaling improves immunoregulation to prevent type 1 diabetes

European Journal of Immunology

Volumn 41, Issue 5, 2011, Pages 1399-1409

  Filippi, Christophe M ^a   Ehrhardt, Katrin ^a   Estes, Elizabeth A ^a   Larsson, Par ^a   Oldham, Janine E ^a   von Herrath, Matthias G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Immunoregulation; TLR2; Tregs; Type 1 diabetes; Virus

Indexed keywords

P3C; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; DENDRITIC CELL; DRUG MECHANISM; FEMALE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; ARENAVIRIDAE INFECTIONS; CELLS, CULTURED; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; PREDIABETIC STATE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955157031     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939841     Document Type: Article

References (50)

1. Eisenbarth, G. S., Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 1986. 314: 1360-1368.
2. Filippi, C. M. and von Herrath, M. G., Viral trigger for type 1 diabetes: pros and cons. Diabetes 2008. 57: 2863-2871.
3. Foulis, A. K., Jackson, R. and Farquharson, M. A., The pancreas in idiopathic Addison's disease--a search for a prediabetic pancreas. Histopathology 1988. 12: 481-490.
4. Horwitz, M. S., Ilic, A., Fine, C., Balasa, B. and Sarvetnick, N., Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin. Immunol. 2004. 110: 134-144.
5. Oldstone, M. B., Nerenberg, M., Southern, P., Price, J. and Lewicki, H., Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991. 65: 319-331.
6. Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B. et al., Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991. 65: 305-317.
7. von Herrath, M. and Holz, A., Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. J. Autoimmun. 1997. 10: 231-238.
8. von Herrath, M. G. and Oldstone, M. B., Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 1997. 185: 531-539.
9. Seewaldt, S., Thomas, H. E., Ejrnaes, M., Christen, U., Wolfe, T., Rodrigo, E., Coon, B. et al., Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 2000. 49: 1801-1809.
10. Christen, U., Wolfe, T., Mohrle, U., Hughes, A. C., Rodrigo, E., Green, E. A., Flavell, R. A. and von Herrath, M. G., A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 2001. 166: 7023-7032.
11. Christen, U., Benke, D., Wolfe, T., Rodrigo, E., Rhode, A., Hughes, A. C., Oldstone, M. B. and von Herrath, M. G., Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 2004. 113: 74-84.
12. Filippi, C. M., Estes, E. A., Oldham, J. E. and von Herrath, M. G., Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J. Clin. Invest. 2009. 119: 1515-1523.
13. Shoda, L. K., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S. et al., A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005. 23: 115-126.
14. Medzhitov, R., Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001. 1: 135-145.
15. Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du, X. and Hoebe, K., Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 2006. 24: 353-389.
16. Moriyama, H., Wen, L., Abiru, N., Liu, E., Yu, L., Miao, D., Gianani, R. et al., Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc. Natl. Acad. Sci. USA 2002. 99: 5539-5544.
17. Lang, K. S., Recher, M., Junt, T., Navarini, A. A., Harris, N. L., Freigang, S., Odermatt, B. et al., Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 2005. 11: 138-145.
18. Kim, H. S., Han, M. S., Chung, K. W., Kim, S., Kim, E., Kim, M. J., Jang, E. et al., Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007. 27: 321-333.
19. Yang, R. B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A. et al., Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998. 395: 284-288.
20. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. and Kirschning, C. J., Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 1999. 274: 17406-17409.
21. Aliprantis, A. O., Yang, R. B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R. et al., Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999. 285: 736-739.
22. Zanin-Zhorov, A., Cahalon, L., Tal, G., Margalit, R., Lider, O. and Cohen, I. R., Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J. Clin. Invest. 2006. 116: 2022-2032.
23. Zhou, S., Kurt-Jones, E. A., Mandell, L., Cerny, A., Chan, M., Golenbock, D. T. and Finberg, R. W., MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 2005. 35: 822-830.
24. Karumuthil-Melethil, S., Perez, N., Li, R. and Vasu, C., Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J. Immunol. 2008. 181: 8323-8334.
25. Serreze, D. V., Hamaguchi, K. and Leiter, E. H., Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 1989. 2: 759-776.
26. Iguchi, M., Inagawa, H., Nishizawa, T., Okutomi, T., Morikawa, A., Soma, G. I. and Mizuno, D., Homeostasis as regulated by activated macrophage. V. Suppression of diabetes mellitus in non-obese diabetic mice by LPSw (a lipopolysaccharide from wheat flour). Chem. Pharm. Bull. (Tokyo) 1992. 40: 1004-1006.
27. Quintana, F. J., Rotem, A., Carmi, P. and Cohen, I. R., Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 2000. 165: 6148-6155.
28. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M. and Demengeot, J., Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003. 197: 403-411.
29. Sutmuller, R. P., den Brok, M. H., Kramer, M., Bennink, E. J., Toonen, L. W., Kullberg, B. J., Joosten, L. A. et al., Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 2006. 116: 485-494.
30. Liu, H., Komai-Koma, M., Xu, D. and Liew, F. Y., Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2006. 103: 7048-7053.
31. Liu, G. and Zhao, Y., Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4(+) CD25(+) T cells. Immunology 2007. 122: 149-156.
32. Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C. et al., Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008. 455: 1109-1113.
33. Sakaguchi, S., Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
34. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A. et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006. 203: 1701-1711.
35. Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L. et al., In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1455-1465.
36. Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P. and Steinman, R. M., CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1467-1477.
37. Probst, H. C. and van den Broek, M., Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 2005. 174: 3920-3924.
38. Homann, D., McGavern, D. B. and Oldstone, M. B., Visualizing the viral burden: phenotypic and functional alterations of T cells and APCs during persistent infection. J. Immunol. 2004. 172: 6239-6250.
39. Filippi, C. M. and von Herrath, M. G., Islet beta-cell death - fuel to sustain autoimmunity? Immunity 2007. 27: 183-185.
40. Yang, X. D. and McDevitt, H. O., Role of TNF-alpha in the development of autoimmunity and the pathogenesis of insulin-dependent diabetes mellitus in NOD mice. Circ. Shock 1994. 43: 198-201.
41. Wu, A. J., Hua, H., Munson, S. H. and McDevitt, H. O., Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 2002. 99: 12287-12292.
42. Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M. and Lipsky, P. E., TNF down-modulates the function of human CD4+CD25hi T regulatory cells. Blood 2006. 108: 253-261.
43. Chen, X., Baumel, M., Mannel, D. N., Howard, O. M. and Oppenheim, J. J., Interaction of TNF with TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells. J. Immunol. 2007. 179: 154-161.
44. Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J. and Michalek, S. M., Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 2003. 171: 717-725.
45. Sing, A., Reithmeier-Rost, D., Granfors, K., Hill, J., Roggenkamp, A. and Heesemann, J., A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc. Natl. Acad. Sci. USA 2005. 102: 16049-16054.
46. Filippi, C. and von Herrath, M., How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol. 2005. 233: 125-132.
47. Elias, D. and Cohen, I. R., Peptide therapy for diabetes in NOD mice. Lancet 1994. 343: 704-706.
48. Raz, I., Elias, D., Avron, A., Tamir, M., Metzger, M. and Cohen, I. R., Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001. 358: 1749-1753.
49. Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R. and Edinger, M., Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 2004. 104: 895-903.
50. Bluestone, J. A., Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. 2005. 5: 343-349.